Background and PurposeIschemia‐reperfusion (I/R) injury is a major contributor to skin flap necrosis, which presents a challenge in achieving satisfactory therapeutic outcomes. Previous studies showed that Cathelicidin‐BF (BF‐30) protects tissues from I/R injury. In this investigation, BF‐30 was synthesized, and its role and mechanism in promoting survival of I/R‐injured skin flaps were explored.Experimental ApproachSurvival rate analysis and laser Doppler blood flow analysis were used to evaluate the I/R‐injured flap viability. Western blotting, immunofluorescence, TdT mediated dUTP Nick End Labeling (TUNEL), and Dihydroethidium were utilized to examine the levels of apoptosis, pyroptosis, oxidative stress, Transcription factor EB (TFEB) mediated autophagy and molecules related to the AMPK‐TRPML1‐Calcineurin signaling pathway.Key ResultsThe outcomes revealed that BF‐30 enhanced the I/R‐injured island skin flaps viability. Autophagy, oxidative stress, pyroptosis, and apoptosis were related to the BF‐30 capability to enhance I/R‐injured flap survival. Improved autophagy flux and tolerance to oxidative stress promote the inhibition of apoptosis and pyroptosis in vascular endothelial cells. The activation of TFEB increases autophagy and inhibits endothelial cells oxidative stress in I/R‐injured flaps. A reduction in TFEB level leads to a loss of the protective effect of BF‐30 by reducing autophagy flux and increasing the accumulation of reactive oxygen species (ROS) in endothelial cells. Additionally, BF‐30 modulated the TFEB activity via the AMPK‐TRPML1‐Calcineurin signaling pathway.Conclusion and ImplicationsBF‐30 promotes I/R‐injured skin flaps survival by TFEB‐mediated upregulation of autophagy and inhibition of oxidative stress, which may have possible clinical applications.